Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Gains from Investment Securities (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Gains from Investment Securities for 10 consecutive years, with $681000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 78.43% to $681000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 23.05% year-over-year, with the annual reading at $397000.0 for FY2025, 279.47% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $681000.0 at Rhythm Pharmaceuticals, up from $49550.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $6.7 million in Q1 2022, with the low at -$1.2 million in Q1 2024.
  • Average Gains from Investment Securities over 5 years is $1.0 million, with a median of $706172.5 recorded in 2022.
  • Peak annual rise in Gains from Investment Securities hit 78825.0% in 2024, while the deepest fall reached 1307.07% in 2024.
  • Over 5 years, Gains from Investment Securities stood at $1.3 million in 2021, then tumbled by 100.08% to -$1000.0 in 2022, then skyrocketed by 500.0% to $4000.0 in 2023, then soared by 78825.0% to $3.2 million in 2024, then tumbled by 78.43% to $681000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $681000.0, $49550.0, and $39545.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.